1. The course and treatment of atopic erythroderma Hill (case study)
- Author
-
L. A. Safonova and T. V. Sokolova
- Subjects
medicine.medical_specialty ,особенности лечения ,business.industry ,peculiarities of treatment ,Erythroderma ,Treatment method ,атопическая эритродермия хилла ,Limiting ,Atopic dermatitis ,Disease ,atopic erythroderma hill (aeh) ,lcsh:RL1-803 ,medicine.disease ,Dermatology ,komfoderm k ,крем метилпреднизолона ацепонат + керамиды ,crem methylprednisolone aceponate + ceramides ,medicine ,lcsh:Dermatology ,Methylprednisolone aceponate ,Treatment procedure ,business ,комфодерм к ,medicine.drug - Abstract
Relevance. Atopic erythroderma Hill (AEH) is a severe variant of the disease. Its occurrence depends on the examined patients and between 1.9% (young men of military age) to 42% (persons admitted to hospital). The treatment procedure is directly related to the presence of trigger factors, aggravating the disease. The purpose of this publication. To analyze the errors of physicians in the choice of Treatment for patients with AEH. Materials and methods. Use material during the examination and treatment of two patients with AEH aged 5 and 17 years in the allergological center of professor Ado A.D. The detailed analysis of the characteristics of AEH and reasons for the ineffectiveness of traditional treatment methods. Main results. Clinical, immunological, bacteriological methods have made it possible to identify trigger factors contributing to the transformation of the classical course of atopic dermatitis in AEH. Limiting their influence helped improve efficiency. Conclusion. The drug of choice for topical therapy AEH is the methylprednisolone aceponate + ceramides (Komfoderm K), which has a pronounced anti-inflammatory and moisturizing effect with the ability to handle up to 60% of the skin within 12 weeks.
- Published
- 2017